© 2020 MJH Life Sciences and HCPLive. All rights reserved.
© 2020 MJH Life Sciences™ and HCPLive. All rights reserved.
October 27, 2020
Researchers test 3 different doses of mirikizumab in both biologic experienced and naïve Crohn’s disease patients.
New research shows patients with chronic liver disease admitted for influenza had an increased risk of disease severity but not a higher odds of mortality.
New phase 1 data show the first-in-class oral therapy is not affected by the burden on metabolism via hepatic or renal disease.
October 26, 2020
A new study presented at ACG shows vedolizumab to be superior to adalimumab in maintaining early disease control in patients with moderate-to-severe ulcerative colitis.
October 25, 2020
The double-blind trial reported on long-term cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes.
October 24, 2020
In data presented during Kidney Week, researchers find the risk of developed an acute kidney injury increased in both sickle cell trail and sickle cell disease patients.